Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome
- PMID: 10980529
- DOI: 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P
Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome
Erratum in
- Hum Mutat 2000 Dec;16(6):527
Abstract
Fifteen children presenting with infantile seizures, acquired microcephaly, and developmental delay were found to have novel heterozygous mutations in the GLUT1 (SLC2A1). We refer to this condition as the Glut-1 Deficiency Syndrome (Glut-1 DS). The encoded protein (Glut-1), which has 12 transmembrane domains, is the major glucose transporter in the mammalian blood-brain barrier. The presence of GLUT1 mutations correlates with reduced cerebrospinal fluid glucose concentrations (hypoglycorrhachia) and reduced erythrocyte glucose transporter activities in the patients. We used Florescence in situ hybridization, PCR, single-stranded DNA conformational polymorphism, and DNA sequencing to identify novel GLUT1 mutations in 15 patients. These abnormalities include one large-scale deletion (hemizygosity), five missense mutations (S66F, R126L, E146K, K256V, R333W), three deletions (266delC, 267A>T; 904delA; 1086delG), three insertions (368-369 insTCCTGCCCACCACGCTCACCACG, 741-742insC, 888-889insG), three splice site mutations (197+1G>A; 1151+1G>T; 857T>G, 858G>A, 858+1del10), and one nonsense mutation (R330X). In addition, six silent mutations were identified in exons 2, 4, 5, 9, and 10. The K256V missense mutation involved the maternally derived allele in the patient and one allele in his mother. A spontaneous R126L missense mutation also was present in the paternally derived allele of the patient. The apparent pathogenicity of these mutations is discussed in relation to the functional domains of Glut-1.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.Ann Neurol. 2005 Jan;57(1):111-8. doi: 10.1002/ana.20331. Ann Neurol. 2005. PMID: 15622525 Clinical Trial.
-
Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.Brain. 2010 Mar;133(Pt 3):655-70. doi: 10.1093/brain/awp336. Epub 2010 Feb 2. Brain. 2010. PMID: 20129935
-
GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier.Nat Genet. 1998 Feb;18(2):188-91. doi: 10.1038/ng0298-188. Nat Genet. 1998. PMID: 9462754
-
Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain-- a review.Eur J Pediatr. 2002 Jun;161(6):295-304. doi: 10.1007/s00431-002-0939-3. Epub 2002 Apr 16. Eur J Pediatr. 2002. PMID: 12029447 Review.
-
[Type 1 glucose transporter (Glut1) deficiency: manifestations of a hereditary neurological syndrome].Rev Neurol. 2004 May 1-15;38(9):860-4. Rev Neurol. 2004. PMID: 15152356 Review. Spanish.
Cited by
-
Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry.Nutrients. 2019 Oct 17;11(10):2497. doi: 10.3390/nu11102497. Nutrients. 2019. PMID: 31627352 Free PMC article. Review.
-
Endothelium-derived lactate is required for pericyte function and blood-brain barrier maintenance.EMBO J. 2022 May 2;41(9):e109890. doi: 10.15252/embj.2021109890. Epub 2022 Mar 3. EMBO J. 2022. PMID: 35243676 Free PMC article.
-
Treatable Genetic Metabolic Epilepsies.Curr Treat Options Neurol. 2017 Sep;19(9):30. doi: 10.1007/s11940-017-0467-0. Curr Treat Options Neurol. 2017. PMID: 28741119 Review.
-
Glucose Transporters Are Key Components of the Human Glucostat.Diabetes. 2024 Aug 1;73(8):1336-1351. doi: 10.2337/db23-0508. Diabetes. 2024. PMID: 38775784 Free PMC article.
-
GLUT-1 deficiency without epilepsy--an exceptional case.J Inherit Metab Dis. 2003;26(6):559-63. doi: 10.1023/a:1025999914822. J Inherit Metab Dis. 2003. PMID: 14605501
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous